Author:
Sachan Nidhi,Srikrishna Saripella,Patel Devendra Kumar,Singh Mahendra Pratap
Publisher
Springer Science and Business Media LLC
Subject
Neuroscience (miscellaneous),Cellular and Molecular Neuroscience,Neurology
Reference37 articles.
1. Calabresi P, Di Lazzaro G, Marino G, Campanelli F, Ghiglieri V (2023) Advances in understanding of the function of alpha-synuclein: implications for Parkinson’s disease. Brain. 146(9):3587–3597. https://doi.org/10.1093/brain/awad150
2. Casanova Y, Negro S, Barcia E (2021) Application of neurotoxin- and pesticide-induced animal models of Parkinson’s disease in the evaluation of new drug delivery systems. Acta Pharm 72(1):35–58. https://doi.org/10.2478/acph-2022-0008
3. Faizan M, Sarkar A, Singh MP (2022) Type 2 diabetes mellitus augments Parkinson’s disease risk or the other way around: facts, challenges and future possibilities. Ageing Res Rev 81:101727. https://doi.org/10.1016/j.arr.2022.101727
4. Singh MP, Patel S, Dikshit M, Gupta YK (2006) Contribution of genomics and proteomics in understanding the role of modifying factors in Parkinson’s disease. Indian J Biochem Biophys 43(2):69–81. http://nopr.niscpr.res.in/handle/123456789/3264
5. Koretsky MJ, Alvarado C, Makarious MB, Vitale D, Levine K, Bandres-Ciga S, Dadu A, Scholz SW et al (2023) Genetic risk factor clustering within and across neurodegenerative diseases. Brain. 146(11):4486–4494. https://doi.org/10.1093/brain/awad161